BioSpace News Archive

Business

MEI Pharma Reports First Quarter Fiscal Year 2020 Results and Operational Highlights

ME-401 emerging as potential best-in-class PI3K delta inhibitor, with Phase 2 study intended to support accelerated approval with FDA in follicular lymphoma underway

November 7, 2019
·
6 min read
Business

Cryoport Revenue Grows 81% for Third Quarter 2019

Revenue from commercial therapies increased 368% over same quarter last year and 39% sequentially

November 7, 2019
·
18 min read
Business

Eiger BioPharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update

Eiger BioPharmaceuticals, Inc., focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, reported financial results for the three and nine months ended September 30, 2019 and provided a business update.

November 7, 2019
·
7 min read
Business

Proteostasis Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Proteostasis Therapeutics, Inc. announced financial results for the third quarter ended September 30, 2019 and provided a corporate update.

November 7, 2019
·
8 min read
Business

Syndax Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Clinical and Business Update

E2112 trial passed final interim OS analysis; trial continues, with final OS analysis expected in 2Q20

November 7, 2019
·
9 min read
Business

Medifast, Inc. Announces Third Quarter 2019 Results

Medifast, Inc., a leading manufacturer and distributor of clinically proven programs and healthy living products, reported results for the third quarter ended September 30, 2019.

November 7, 2019
·
11 min read
Business

Penumbra, Inc. Reports Third Quarter 2019 Financial Results

Penumbra, Inc., a global healthcare company focused on innovative therapies, reported financial results for the third quarter ended September 30, 2019.

November 7, 2019
·
15 min read
Business

NovaBay Pharmaceuticals Reports 2019 Third Quarter Financial Results

NovaBay® Pharmaceuticals, Inc., a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, reports financial results for the three and nine months ended September 30, 2019 and provides a business update.

November 7, 2019
·
8 min read
Business

Cutera Reports Third Quarter 2019 Financial Results

Cutera, Inc. reported financial results for the third quarter ended September 30, 2019.

November 7, 2019
·
10 min read
Business

Spectrum Pharmaceuticals Reports Third Quarter 2019 Financial Results and Pipeline Update

Basket trial initiated to study poziotinib in patients with EGFR or HER2 mutation-positive malignant solid tumors in an investigator-led study at The University of Texas MD Anderson Cancer Center

November 7, 2019
·
7 min read